Skip to content

The prevalence of dyspepsia and IBS in patients with gallstones.

Prevalence of Functional Gastrointestinal Diseases (FGID) in Patients with uncomplicated Cholecystolithiasis; a prospective multicentre Study.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON27555
Enrollment
385
Registered
2018-06-18
Start date
2018-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallstones, Cholecystolithiasis, Dyspepsia, Irritable Bowel Syndrome, Cholecystectomy.

Interventions

Questionnaires: Rome IV Diagnostic Questionnaire for Functional Gastrointestinal Disorders in Adults (R4DQ) PAGI-SYM Izbicki Pain Score (IPS) Gallstone Symptom List (GSL) Hospital Anxiety and De

Sponsors

Radboud University Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - 18 years of age or older, and - with ultrasonically proven, uncomplicated cholecystolithiasis, and - referred for surgical consultation

Exclusion criteria

Exclusion criteria: - History of complicated cholelithiasis (i.e. choledocholithiasis, acute cholecystitis, biliary pancreatitis or cholangitis) - Current schizophrenia, memory deficiency, or any other disorder that predispose them to unreliable questionnaire responses; - Mentally incompetent; - Insufficient knowledge of the Dutch language; - Known pregnancy

Design outcomes

Primary

MeasureTime frame
The prevalence of Functional Dyspepsia (FD) and Irritable Bowel Syndrome (IBS) according to the ROME IV criteria.

Secondary

MeasureTime frame
- What is the prevalence of gastroduodenal disorders and bowel disorders separately? - What is the prevalence of overweight and obesity in the study population? - Is the prevalence of patients with FGID that are scheduled for cholecystectomy different from those not scheduled? - Which additional diagnostic tests are performed in patients not scheduled for surgery? - Which therapeutic interventions are performed in patients not scheduled for surgery? - Has symptom severity changed six months after the visit to the outpatient clinic and what is the influence of cholecystectomy on symptom severity? - Is there a correlation between aspects (such as wall thickness) and motility of the gallbladder on ultrasonic and pathological examination, and the presence of FGID?

Contacts

Public ContactCarmen Latenstein

Huispost 618, Postbus 9101

carmen.latenstein@radboudumc.nl06-19402554

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)